4 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Peripheral Neuropathy: new trials by email Literature Review of Peripheral Neuropathy trials Research Report on Peripheral Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daratumumab for Polyneuropathy Associated With MGUS Daratumumab and hyaluronidase-fihj - Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance | Phase 2 | Withdrawn | Georgetown University | 2025-09-26 | 2025-10-01 | |
| Evaluation of Hydroxychloroquine to Prevent CIPN Hydroxychloroquine - Breast Cancer, Gynecologic Cancer | Phase 2 | Withdrawn | University of Arizona | 2024-06-01 | 2024-03-08 | |
| NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy Placebo, NBP Softgel Capsules - Breast Cancer, Peripheral Neuropathy | Phase 2 | Withdrawn | Conjupro Biotherapeutics, Inc. | 2023-06-30 | 2023-06-08 | |
| SINF: Peripheral Neuropathy in Cancer Survivors Acupuncture, Nerve Function Tests, Questionnaires - Peripheral Neuropathy | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2016-03-01 | 2016-03-08 |
Peripheral Nervous System Diseases (4) · Breast Neoplasms (2) · Monoclonal Gammopathy of Undetermined Significance (1)
Nervous System Diseases (4) · Neuromuscular Diseases (4) · Breast Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Blood Protein Disorders (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hypergammaglobulinemia (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Paraproteinemias (1)
Acupuncture Therapy (1) · Hydroxychloroquine (1) · Surveys and Questionnaires (1) · daratumumab (1)
Conjupro Biotherapeutics, Inc. (1) · Georgetown University (1) · M.D. Anderson Cancer Center (1) · University of Arizona (1)
United States (1)
Jennifer Segar, MD (1) · Kimberley Doucette, MD (1) · Qingxi Wang, PhD (1) · Richard T. Lee, MD (1)